TØ
Therapeutic Areas
Caedo Oncology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CO-1 | Cancer | Pre-clinical |
| Anti-CD99 monoclonal antibody | Cancer | Discovery/Pre-clinical |
| Anti-HLA class I monoclonal antibody | Cancer | Discovery/Pre-clinical |
Leadership Team at Caedo Oncology
KH
Kjetil Hestdal
Co-founder and CEO
RD
Rolf D. Pettersen
Co-founder and Scientific Advisor/Board Member
PL
Pierre Launay
Scientific and Technical Advisor
TB
Tim Buss
Antibody Engineering Advisor
ØÅ
Øystein Åmellem
Business development advisor
ES
Erlend Skagseth
Chairperson of Board
OJ
Ole J. Dahlberg
Board member
FA
Farzad Abdi-Dezfuli
Board Member